首页 › 基金 › Vivo Capital, LLC › ENTX

Vivo Capital, LLC 对 ENTX 的持仓历史

Entera Bio Ltd · 医疗保健

Vivo Capital, LLC 在 Q3 2026 的 13F 申报中披露持有 ENTX(Entera Bio Ltd)12,254,901 股,市值约 US$35.7M,约占其申报组合的 4.05%,在其申报持仓中市值排名第 6 位。 Vivo Capital, LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)12.25M 股
申报持仓市值$35.66M
组合权重4.05%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Vivo Capital, LLC 对 ENTX 的持仓演变

Vivo Capital, LLC 于 Q3 2026 首次披露 ENTX 持仓:12,254,901 股(约 US$35.7M)。

逐季持仓明细

季度股数金额变化
Q3 2026 12.25M $35.66M 新进

关于 ENTX 与 13F 数据

ENTX(Entera Bio Ltd)属于医疗保健行业。我们追踪的基金中还有 29 只申报持有 ENTX,申报仓位最大的包括:Knoll Capital Management, LLC (US$10.4M), NEXTBio Capital Management LP (US$8.5M), BVF INC/IL (US$4.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ENTX 的基金

查看 ENTX 的全部基金持有人 →

常见问题

How long has Vivo Capital, LLC held ENTX?

Vivo Capital, LLC has disclosed ENTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Vivo Capital, LLC's current position in ENTX?

As of Q3 2026, Vivo Capital, LLC holds 12.25M shares of ENTX (Entera Bio Ltd), valued at $35.66M, representing 4.05% of its reported portfolio and ranking #6.

Has Vivo Capital, LLC been buying or selling ENTX?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC newly opened its position in ENTX.

Which other funds hold ENTX?

Other major institutional holders of ENTX include Knoll Capital Management, LLC, NEXTBio Capital Management LP, BVF INC/IL, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.